Reporting of Noninferiority and Equivalence Randomized Trials Extension of the CONSORT 2010 Statement

被引:1035
作者
Piaggio, Gilda [1 ,2 ,3 ]
Elbourne, Diana R. [3 ]
Pocock, Stuart J. [3 ]
Evans, Stephen J. W. [3 ]
Altman, Douglas G. [4 ]
机构
[1] Stat Consultoria, F-01220 Divonne Les Bains, France
[2] Stat Consultoria, Sao Paulo, Brazil
[3] London Sch Hyg & Trop Med, Dept Med Stat, London WC1, England
[4] Univ Oxford, Ctr Stat Med, Oxford, England
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2012年 / 308卷 / 24期
基金
英国医学研究理事会;
关键词
NON-INFERIORITY TRIALS; CLINICAL-TRIALS; DOUBLE-BLIND; ACTIVE-W; EXPLANATION; ISSUES; MULTICENTER; PREVENTION; QUALITY; CANCER;
D O I
10.1001/jama.2012.87802
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The CONSORT (Consolidated Standards of Reporting Trials) Statement, which includes a checklist and a flow diagram, is a guideline developed to help authors improve the reporting of the findings from randomized controlled trials. It was updated most recently in 2010. Its primary focus is on individually randomized trials with 2 parallel groups that assess the possible superiority of one treatment compared with another. The CONSORT Statement has been extended to other trial designs such as cluster randomization, and recommendations for noninferiority and equivalence trials were made in 2006. In this article, we present an updated extension of the CONSORT checklist for reporting noninferiority and equivalence trials, based on the 2010 version of the CONSORT Statement and the 2008 CONSORT Statement for the reporting of abstracts, and provide illustrative examples and explanations for those items that differ from the main 2010 CONSORT checklist. The intent is to improve reporting of noninferiority and equivalence trials, enabling readers to assess the reliability of their results and conclusions. JAMA. 2012;308(24).2594-2604 www.jama.com
引用
收藏
页码:2594 / 2604
页数:11
相关论文
共 68 条
[1]   The revised CONSORT statement for reporting randomized trials: Explanation and elaboration [J].
Altman, DG ;
Schulz, KF ;
Moher, D ;
Egger, M ;
Davidoff, F ;
Elbourne, D ;
Gotzsche, PC ;
Lang, T .
ANNALS OF INTERNAL MEDICINE, 2001, 134 (08) :663-694
[3]  
[Anonymous], 2003, Testing statistical hypotheses of equivalence
[4]  
[Anonymous], 2010, Guidance for industry non-inferiority clinical trials
[5]  
[Anonymous], [No title captured]
[6]   Improving the quality of reporting of randomized controlled trials - The CONSORT statement [J].
Begg, C ;
Cho, M ;
Eastwood, S ;
Horton, R ;
Moher, D ;
Olkin, I ;
Pitkin, R ;
Rennie, D ;
Schulz, KF ;
Simel, D ;
Stroup, DF .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (08) :637-639
[7]   Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: Explanation and elaboration [J].
Boutron, Isabelle ;
Moher, David ;
Altman, Douglas G. ;
Schulz, Kenneth F. ;
Ravaud, Philippe .
ANNALS OF INTERNAL MEDICINE, 2008, 148 (04) :295-309
[8]   An introductory note to the CHMP guidelines: choice of the non-inferiority margin and data monitoring committees [J].
Brown, David ;
Volkers, Peter ;
Day, Simon .
STATISTICS IN MEDICINE, 2007, 26 (01) :230-233
[9]   Monitoring the ACTIVE-W trial: Some issues in monitoring a noninferiority trial [J].
Cairns, John A. ;
Wittes, Janet ;
Wyse, D. George ;
Pogue, Janet ;
Gent, Michael ;
Hirsh, Jack ;
Marler, John ;
Pritchett, Edward L. C. .
AMERICAN HEART JOURNAL, 2008, 155 (01) :33-41
[10]   Consort 2010 statement: extension to cluster randomised trials [J].
Campbell, Marion K. ;
Piaggio, Gilda ;
Elbourne, Diana R. ;
Altman, Douglas G. .
BMJ-BRITISH MEDICAL JOURNAL, 2012, 345